Of note, hepatic steatosis is usually associated to liver n-3 long-chain polyunsaturated fatty acid depletion, thereby leading to substantial enhancement in hepatic sterol regulatory element binding protein (SREBP)-1c/PPARα ratio that favors de novo lipogenesis over fatty acid β-oxidation [28, 29]. The gene discussed is SREBF1; the disease is fatty liver disease.